2024-09-04 - Analysis Report
## INTU Stock Analysis Report

**Company Overview:** INTU (Intuitive Surgical, Inc.) is a leading provider of minimally invasive surgical systems and instruments.

**Performance Analysis:**

**1.  Return Comparison:**

*   INTU's cumulative return is 149.62%, significantly higher than the S&P 500's return of 89.66%. This reflects a strong outperformance relative to the broader market.
*   The current return gap is 59.96%, placing it at the 43.23% percentile of historical return differences. This suggests that INTU has outperformed the S&P 500 by a considerable margin, but is currently closer to its historical average performance relative to the benchmark.

**2. Recent Price Movement:**

*   The current closing price is 630.26.
*   The stock is currently trading slightly below its 20-day moving average (634.82) and 60-day moving average (631.17), while above its 5-day moving average (622.71).  This indicates potential downward pressure in the short term, but overall stability in the medium to long term.

**3. Technical Indicators:**

*   RSI (50.97) is close to neutral territory, suggesting the stock is neither overbought nor oversold.
*   PPO (-0.45) is slightly negative, hinting at a potential for short-term price weakness.
*   The recent 20-day relative divergence shows a negative trend (-5.59), indicating a short-term downward trend.
*   The expected return (78.84%) signifies a strong potential for long-term growth, particularly for investors with a long-term investment horizon (5 years).

**4. Recent Earnings and Outlook:**

| Date        | EPS   | Revenue |
|-------------|-------|---------|
| 2024-05-23 | 8.53  | 6.74 B$ |
| 2024-02-22 | 1.26  | 3.39 B$ |
| 2023-11-28 | 0.86  | 2.98 B$ |
| 2023-05-23 | 7.44  | 6.02 B$ |

*   INTU consistently outperforms earnings expectations, with strong revenue growth in the recent quarter (2024-05-23). This suggests a healthy underlying business and a positive future outlook.

**5.  Overall Analysis:**

INTU exhibits a robust long-term growth trajectory, significantly outperforming the market with consistent revenue and earnings growth. While the recent short-term trend suggests a slight slowdown, the long-term growth potential remains strong. The company's innovative technology and leadership position in the minimally invasive surgery market provide a solid foundation for future success. 

**6.  Recommendation:**

INTU remains a strong investment option for long-term investors seeking exposure to the healthcare sector. The company's consistent growth, high expected return, and leadership position in its market make it a compelling choice for portfolio diversification and potential long-term gains.  However, investors should consider the short-term downward pressure and closely monitor market developments before making investment decisions. 
